The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Here's your Monthly Dose my supplement spotlight on what's trending, what's promising, and what actually holds up under scientific scrutiny. This month: BPC 157. Often called the injury recovery peptide, BPC 157 has Have patients been harmed by unsafe drug compounding? Partnership for Safe Medicines FDA mulls compounding for peptides previously flagged over safety risks BioSpace